Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026)
Biolife Solutions' (BLFS) quarterly Income from Continuing Operations came in at $45.1 million in Q2 2026, up 394.39% year-over-year from $9.1 million in Q2 2025, and up 3828.92% quarter-over-quarter from $1.1 million in Q1 2026.
Analysis
Biolife Solutions (BLFS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Income from Continuing Operations for 17 consecutive years, with $45.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 394.39% year-over-year to $45.1 million in Q2 2026; TTM through Jun 2026 was $50.4 million, a 434.36% increase from a year earlier, with the FY2025 full-year figure at -$12.1 million, down 38.08% from the prior year.
- Income from Continuing Operations was $45.1 million for Q2 2026 at Biolife Solutions, up from $1.1 million in the prior quarter.
- Over five years, Income from Continuing Operations peaked at $91.0 million in Q4 2022 and troughed at -$72.9 million in Q2 2022.
- A 5-year average of $545055.6 and a median of -$1.8 million in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 13159.49% in 2022 and jumped 694.38% in 2025, its largest moves.
- Over 5 years, Income from Continuing Operations stood at $91.0 million in 2022, then plunged by 80.35% to $17.9 million in 2023, then sank by 97.51% to $445000.0 in 2024, then jumped by 694.38% to $3.5 million in 2025, then jumped by 1175.93% to $45.1 million in 2026.
- The last three Income from Continuing Operations figures came in at $45.1 million (Q2 2026), $1.1 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.35 Bn | 219.29 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 141.93 Bn | 137.59 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Agilent Technologies | 40.25 Bn | 38.49 Bn | 1.04 Bn | 362.00 Mn |
| 4 | Illumina | 30.62 Bn | 29.46 Bn | 770.00 Mn | 207.00 Mn |
| 5 | Revvity | 13.52 Bn | 12.49 Bn | 416.87 Mn | 53.48 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 54.62 Mn |
| 7 | Bio-Rad Laboratories | 9.91 Bn | 8.30 Bn | 345.80 Mn | 371.40 Mn |
| 8 | Repligen | 9.20 Bn | 8.19 Bn | 110.04 Mn | 5.01 Mn |
| 9 | 10x Genomics | 8.70 Bn | 8.15 Bn | 112.50 Mn | -17.93 Mn |
| 10 | Biolife Solutions | 1.70 Bn | 1.61 Bn | 18.29 Mn | 45.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.10 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 3.54 Mn |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | -15.32 Mn |
| Mar 31, 2025 | 271,000.00 |
| Dec 31, 2024 | 445,000.00 |
| Sep 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -5.56 Mn |
| Mar 31, 2024 | -3.20 Mn |
| Dec 31, 2023 | 17.89 Mn |
| Sep 30, 2023 | -15.80 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -13.71 Mn |
| Dec 31, 2022 | 91.00 Mn |
| Sep 30, 2022 | -10.32 Mn |
| Jun 30, 2022 | -72.88 Mn |
| Mar 31, 2022 | -7.42 Mn |
| Dec 31, 2021 | -15.75 Mn |
| Sep 30, 2021 | 79,000.00 |